entity

multiple endocrine neoplasia syndrome type 2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about multiple endocrine neoplasia syndrome type 2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
0Analyses
1Outgoing
0Incoming

Wiki Pages (3)

Knowledge base pages for this entity

section-209-glp-1-receptor-agonists-cbs-psp

therapeutic · 2422 words

Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegeneration

therapeutic · 2057 words

Semaglutide EVOKE Plus (NCT04777409)

clinical · 1155 words

Outgoing (1)

TargetRelationTypeStr
semaglutideassociated_withdrug0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found